Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-003334
Filing Date
2023-04-03
Accepted
2023-04-03 14:30:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27657
2 filename2.txt TEXT-EXTRACT 1481
  Complete submission text file 0000000000-23-003334.txt   40236
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Filed for) CIK: 0001722964 (see all company filings)

EIN.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations